>_ QFI Terminal
TerminalStocks › TMO

Thermo Fisher Scientific Inc. (TMO) Stock

Healthcare · Medical - Diagnostics & Research · US
$651.45 -1.04%
Last updated Sep 20, 2026 13:07 UTC

TMO Key Statistics

Market Cap$242.09B
P/E (TTM)35.04
P/S (TTM)5.22
P/B (TTM)4.59
Revenue (TTM)$46.34B
EPS (TTM)$18.59
Dividend Yield0.28%
ROE (TTM)13.35%
Net Margin15.06%
Gross Margin40.37%
52W High$663.57
52W Low$435.27
Analyst ViewBuy
Price Target$623.36
Employees125,000
Volume4,301,667

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

CEO: Marc N. Casper. Company website

TMO — Frequently Asked Questions

What is the TMO stock price today?

Thermo Fisher Scientific Inc. (TMO) trades at $651.45, down 1.04% on the day, as of Sep 20, 2026 13:07 UTC.

What is Thermo Fisher Scientific Inc.'s market cap?

Thermo Fisher Scientific Inc. has a market capitalisation of $242.09B, calculated from the live TMO share price and shares outstanding.

What is the P/E ratio of TMO?

TMO trades at a trailing P/E of 35.04, from earnings per share of $18.59 over the last twelve months.

How much revenue does Thermo Fisher Scientific Inc. make?

Thermo Fisher Scientific Inc. generated revenue of $46.34B over the trailing twelve months, which puts the stock at 5.22 times sales.

Does TMO pay a dividend?

Yes. Thermo Fisher Scientific Inc. pays a dividend yielding 0.28% on the current share price.

What is the 52-week range for TMO?

TMO has traded between $435.27 and $663.57 over the past 52 weeks, and the last price is 1.8% below that high.

Is Thermo Fisher Scientific Inc. profitable?

Yes. Thermo Fisher Scientific Inc. keeps 15.06% of revenue as net income over the trailing twelve months.

What is the analyst price target for TMO?

Wall Street analysts rate TMO Buy, with an average price target of $623.36, 4.3% below the current price.

What sector is Thermo Fisher Scientific Inc. in?

Thermo Fisher Scientific Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of Thermo Fisher Scientific Inc.?

Marc N. Casper is the chief executive of Thermo Fisher Scientific Inc., which employs 125,000 people.

Where can I track TMO in real time?

QFI Terminal shows TMO with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See TMO live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open TMO in Terminal See plans

Medical - Diagnostics & Research stocks

DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation IDXX IDEXX Laboratories, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.